Information Center

News

Total 67

News Search
  • Samyang Group 2017.09.26
    Chairman Kim Yoon Held the 49th Korea-Japan Business Conference
    Chairman Kim Yoon Held the 49th Korea-Japan Business Conference

    ▲ Chairman Kim Yoon (Chairman of Korea Japan Economic Association) giving an opening address at the 49th Korea-Japan Business Conference   ▲ Chairman Kim Yoon (third from the left) standing for a commemorative photograph at the 49th Korea-Japan Business Conference   Chairman Kim Yoon held the 49th Korea-Japan Business Conference at Lotte Hotel Seoul from September 26 to 27. The Korea-Japan Business Conference is an annual event where Korean and Japanese CEOs discuss ways to promote economic cooperation between two countries. This year, as many as 300 business leaders attended the conference sponsored by the Ministry of Trade, Industry and Energy.   The conference was held under the theme of “Rapidly Changing International Situations and New Direction of Korea-Japan Cooperation - Open the Era of the Fourth Industrial Revolution Together!” During the conference, attendees discussed future-oriented Korea-Japan cooperation for the next 50 years.   In the opening speech on September 26, Chairman Kim Yoon (Chairman of Korea-Japan Economic Association) said, “Korea and Japan have been neighbors geographically for a thousand years and will still be neighbors a thousand years from now. Regardless of the conflicts between our two countries, we have to cooperate and compete with each other in good faith for coexistence.” He suggested that two countries should open the era of the Fourth Industrial Revolution together by challenging new business fields.  

  • Samyang Group 2017.09.18
    Chairman Kim Yoon Attended the Appointment Ceremony of the 6th Parang Manito
    Chairman Kim Yoon Attended the Appointment Ceremony of the 6th Parang Manito

      On September 18, Chairman Kim Yoon attended the appointment ceremony of the 6th Parang Manito held in the auditorium of Seoul Central District Prosecutors’ Office as the chairman of Youth Hope Foundation. Parang Manito, sponsored by Youth Hope Foundation, is a one-on-one mentoring program between teenagers feeling lost and adult mentors. Parang Manito is provided to help students adjust to their daily lives and executives and employees of Samyang Group are actively taking part in the program. As many as 90 people including nine employees of Samyang Group who will participate in Parang Manito as mentors, college students, and officials at the prosecutors’ office attended this event. The program consisted of Chairman Kim Yoon’s Introductory Greetings, Introduction of Parang Manito Activities, Sharing of Excellent Mentoring Cases, and Presentation of Letters of Appointment, etc.

  • Samyang Biopharm 2017.07.07
    Samyang Biopharm Held Samyang Discovery Center Opening Symposium
    Samyang Biopharm Held Samyang Discovery Center Opening Symposium

    ▲ Samyang Biopharm held Samyang Discovery Center Opening Symposium on July 7.   ▲ Chairman Kim Yoon looking around the medicine exhibition booth at the symposium   ▲ Samyang Biopharm CEO Eom Tae-ung delivering a welcoming speech   ▲ CSO (Chief Strategy Officer) Hyunjung Helen Lee introducing R&D of Samyang Biopharm   ▲ Professor John Bell (University of Ottawa) giving a lecture at Samyang Discovery Center Opening Symposium   On July 7, Samyang Biopharm (CEO: Eom Tae-ung) held a symposium entitled “New Trends of Chemotherapy” in Samyang Discovery Center Auditorium. The symposium was held to commemorate the completion of Samyang Discovery Center. In this symposium, Samyang Biopharm shared the latest trends of research on anticancer drugs with noted Korean and foreign experts and encouraged exchange between participants. As many as 200 people including Korean and foreign researchers, entrepreneurs, and heads of associations relating to chemotherapy participated in the event composed of the official event and the symposium. In the official event, Korea Pharmaceutical and Bio-Pharma Manufacturers Association Chairman Won Hee-mok and Chair-Professor Kim Sung-wan (University of Utah) celebrated the opening of the symposium delivered a congratulatory speech. In addition, Professor Kim Yong-man from Asan Medical Center announced the clinical results of Genexol® PM of Samyang Biopharm. During the symposium, attendees published the results of recent research on immune checkpoint inhibitors, which are the most noteworthy anticancer drug these days, and development of anticancer drugs using viruses. In addition, Professor Bang Yung-jue (Seoul National University), Professor John Bell (University of Ottawa), Professor Omid C. Farokhzad (Harvard University), and Professor Dennis Discher (University of Pennsylvania) attracted attention of visitors by giving a presentation under the theme of “Immune Checkpoint Inhibitors in Gastrointestinal Cancers”, “Oncolytic Virus Combination Therapy Approaches”, “Nanoparticles for Cancer Therapy and Immune Tolerance : From Bench to the Clinic”, and “Interactions of Drug Delivery System with Macrophages as a Foundation for Engineered Macrophage Anti-Cancer Therapy”, respectively. In the welcoming speech, Samyang Biopharm CEO Eom Tae-ung said, “Samyang Biopharm will realize C&D through communication with outside experts. We will make efforts so that Samyang Biopharm can become an R&D hub leading the chemotherapy trends in the future.”

  • Samyang Biopharm 2017.06.09
    Samyang Biopharm Invited Foreign Cancer Specialists and Held a Seminar
    Samyang Biopharm Invited Foreign Cancer Specialists and Held a Seminar

      Samyang Biopharm invited as many as 60 noted cancer specialists from Southeast Asia and held a seminar for six days from June 19 to 25. This seminar is held annually by PT Kalbe Farma Tbk from Indonesia, Mermisi from Georgia, and Samyang Biopharm in order to develop their competencies in anticancer drugs. During the seminar, anticancer specialists looked around anticancer drug manufacturing facilities of Samyang Biopharm Pharmaceuticals Plant, attended the 24th Asia Pacific Cancer Conference held in COEX, and shared their clinical experience and opinions.

  • Samyang Group 2017.06.02
    Samyang Discovery Center Holds an Opening Ceremony
    Samyang Discovery Center Holds an Opening Ceremony

    Samyang Group has completed its R & D center (Samyang Discovery Center) with advanced research facilities in Pangyo, Seongnam City, and held an opening ceremony in the hopes of taking a bold leap forward into becoming a global R & D company.   Chairman Yoon Kim revealed future plans in his welcome speech: “We will now take a big step closer to realizing the group's vision of a company making life more convenient. We can get to that goal now by strengthening global R & D capabilities using this Samyang Discovery Center as a stepping stone. We will also promote internal communication within the group and facilitate open innovation through collaboration with various domestic and overseas research institutes."   The ceremony was attended by about 60 guests, including key figures from the chemical, food and pharmaceutical biotechnology industry, and heads of different institutes and associations, who all celebrated the completion of the center.   Samyang Discovery Center is located in Pangyo-ro, Bundang-gu and has a total floor area of 44,984 square meters with 9 floors above ground and 6 floors below ground. Approximately 400 researchers and marketing personnel in the food and pharmaceutical biotechnology divisions are working in the center in step with the strategy that the marketing division and research institute communicate closely and generate innovation synergy.   In addition, Samyang Discovery Center possesses a variety of facilities to enable internal and external communication such as special communication spaces on the corners on each floor and the Food Lab to provide hands-on experiences of Samyang products. In particular, the Food Lab for direct communication with customers is the first case of its kind in the B2B industry.   In addition to state-of-the-art research facilities, the group seeks to enhance the efficiency of employees by providing a diverse range of welfare facilities such as day care centers, fitness centers, music lounges and rooftop gardens.   Meanwhile, Samyang Group has been organizing the annual Samyang Innovation R & D Fair (SIRF), in which researchers from all business fields, such as chemicals, food, pharmaceutical biotechnology and information & electronic materials gather and share the latest news and progress in technology and development orientation as a means to pursue innovations through R & D.  

  • Samyang Group 2017.05.31
    Samyang Biopharm Holds a Seminar about Chinese Pharmaceutical Industry
    Samyang Biopharm Holds a Seminar about Chinese Pharmaceutical Industry

    Samyang Biopharm held a seminar on May 31 at Samyang Discovery Center to introduce the current trends of the Chinese pharmaceutical industry along with research and development. The seminar was held to review and discuss the recent rapid growth in China's technological competitiveness, the rapid expansion of the Chinese pharmaceutical market, introducing the full range of activities of multinational pharmaceutical companies in China.   Samyang Biopharm will continue to hold seminars related to the pharmaceutical industry in the future and plans to utilize these seminars towards improving employee competencies and uncovering research and development ideas.  

  • Samyang Group 2017.05.16
    Samyang Corporation’s AM BU Participates in ‘CHINAPLAS 2017’
    Samyang Corporation’s AM BU Participates in ‘CHINAPLAS 2017’

    Samyang Corporation participated CHINAPLAS 2017 from last May 16 to 19. CHINAPLAS is the largest plastic and rubber exhibition in Asia that is held every year in Shanghai and Guangzhou on a rotation basis, and this year, as many as 3,300 exhibitors from 40 countries around the world participated in the venue. AM BU exhibited 13 engineering plastic materials, TPEE, LFT, and isosorbide of industrial biotechnology with an exhibition concept of “a professional compounding company that compounds various materials.”  

  • Samyang Group 2017.04.05
    Samyang Corporation Launches Two Allulose products in Trusweet line
    Samyang Corporation Launches Two Allulose products in Trusweet line

    Through leveraging the next-generation sweetener, allulose, Samyang Corporation's Q.one introduces Trusweet Allulose and Trusweet Allulose Oligosaccharides, which are lower in calories than conventional liquid sugar.   Trusweet Allulose, which is made from Q.one's unique enzyme technology, contains 99.1% of allulose. Its calories are lowered to one-tenth of that of the existing sweetener products of the company. Trusweet Allulose Oligosaccharide contains 60% of allulose and 39.4% of fructooligosaccharides, which has half the calories of the existing oligosaccharide products of the company. Allulose has a sweetness close to that of sugar (70% sweetness of sugar) but 0 kcal per 1g. In particular, Trusweet Allulose uses high-sweetening agents derived from stevia leaves, distinguishing it from other similar products.      

  • Samyang Group 2017.03.15
    Vice Chairman Kim Won Receives the ‘Gold Tower Order of Industrial Service Merit’
    Vice Chairman Kim Won Receives the ‘Gold Tower Order of Industrial Service Merit’

      On March 15, Vice Chairman Kim Won received the Gold Tower Order of Industrial Service Merit at the celebration of the 44th Commerce and Industry Day that as held at the International Conference Room of the Korea Chamber of Commerce and Industry.     Since joining the company in 1988, he has worked in the various business divisions of Samyang Group and has helped form the foundation for future growth of the group.   In the chemical division, he built a full-scale production line for producing everything from raw materials for plastics to finished products, and focused on developing new products, which led to the establishment of Asia's largest chemical companies such as Samyang Innochem and Samyang Fine Technology. In the field of medical biotechnology, the company has since become recognized for its technological prowess in surgical sutures (the world's third largest) and anticancer drugs.   Since 2011, Kim has been the vice chairman of Samyang Holdings, a holding company of Samyang Group, and has been managing general businesses of the holding company, leading not only the growth of pharmaceutical biotechnology business but also the globalization of chemical business and the optimization of the overall portfolio of the food business.   In addition, with his business philosophy of "field management" that always finds solutions in the fields coupled with his mild leadership, he has been able to guide team leaders of the group in a friendly manner, strongly motivating them to create exemplary results.    

  • Samyang Group 2017.03.07
    Samyang Packaging Participates in ‘FOODEX JAPAN 2017’
    Samyang Packaging Participates in ‘FOODEX JAPAN 2017’

        From March 7 to 10, Samyang Packaging participated in FOODEX JAPAN 2017 (The 42nd Tokyo International Food and Beverage Exhibition) that was held in Japan. FOODEX JAPAN is one of the three largest food exhibitions in the world, and this year, it was able to draw over 3,000 companies and 78,000 food buyers from 80 countries. Samyang Packaging chose to participate in the fair in an effort to discover overseas buyers and expand sales of its beverage, Aseptic, while also introducing the drinks, coffee, juice, and other beverages produced by the company.    

First Page 1 2 3 4 5 6 7 Next Page Last Page